-
The lancet oncology · Jan 2022
Comment LetterRadiographic progression-free survival in the ACIS trial for prostate cancer.
- Ian F Tannock, Christopher M Booth, Bishal Gyawali, and Anthony M Joshua.
- Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada. Electronic address: ian.tannock@uhn.ca.
- Lancet Oncol. 2022 Jan 1; 23 (1): e4.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:

- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.